Skip to the card

2026-11-21 issue

Observed arrival · 2026-11-21

FDA Brief turns enforcement records into watchlists

fdabrief.com Visit website
Editorial interest 78/100 Selection signal · not a rating of the site

A plain-English guide to FDA warning letters and recalls, with alerts for companies, suppliers, competitors, or topics.

Landing page captured for the 2026-11-21 issue.
For
Food and drug supply-chain teams tracking FDA actions
Worth noticing
The homepage lists 3,813 warning letters and 59 Class I recalls from the last 30 days.

Field notes

The page separates warning letters from Class I recalls and shows company names, dates, risk labels, and short issue summaries. One featured letter concerns Natural Essentials’ OTC manufacturing controls; the excerpt names inadequate investigations of failing results, missing component identity tests, and an FDA response review it found inadequate. The homepage figures are site-reported and are not independently verified here.

Observed signals

Read the marks

Editorial observations of this landing page, not a rating.

○OpenPublic substance visible
⊠LoginAccess appeared gated
✦PrettyNotable craft visible
●ProPolished or operationally mature
◎NicheUnusually specific use

One card from the complete issue

Straw-Goat Rehearsal

333,779 arrived 1,000 judged 980 catalogued Enter the complete issue
fdabrief.com

Landing page observed 2026-11-21. The live site may have changed.